Emmaus Life Sciences Inc (EMMAW) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access EMMAW Annual Balance Sheets →
This page allows investors to track Emmaus Life Sciences Inc's balance sheet development across multiple reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Jun 30 2025) (Mar 31 2025) (Dec 31 2024) (Sep 30 2024)
Assets
Cash & cash equivalent2.13
Cash & Short-term Investments2.00
Accounts receivable2.80
Inventories1.56
Other Current Assets0.00
Prepaid Expense And Other Assets Current1.26
Total Current Assets7.75
Equipment/Property/Plant Net0.11
Other Assets, Noncurrent13.58
Due From Factoring Of Accounts Receivable-
Operating Lease Right Of Use Asset0.77
Total Assets21.44
Liabilities
Accounts Payable and Accrued Liabilities, Current LI22.62
Derivative Instruments and Hedges, Liabilities LI0.01
Convertible Notes Payable, Current NO17.38
Other Liabilities, Current29.06
Total Current Liabilities69.07
Total Long-term Debt0.00
Other liabilities, Noncurrent15.97
Operating Lease Liability Current0.35
Notes Payable Current Excluding Convertible Notes Payable Current8.02
Operating Lease Liability Noncurrent1.41
Long Term Notes Payable Excluding Convertible Long Term Notes Payable2.27
Total Liabilities85.04
Stockholders' Equity
Common Stock Value0.07
Additional Paid In Capital Common Stock225.99
Retained Earnings / Accumulated Deficit-16.87
Other Equity-272.80
Common Stockholder's Equity-63.61
Total Stockholder's Equity-63.61
Liabilities & Stockholder's Equity21.44
4 historic quarters locked

Sign in to unlock the full Emmaus Life Sciences Inc balance sheet history.

About Emmaus Life Sciences Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-351833

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.